NFKB1 and B-cell chronic lymphocytic leukemia: To investigate the role of NFκB on the gene expression response to IL-4 in CLL, we used a quinazoline that inhibits the transactivation capacity of NFκB [35], in a ZAP-70 positive patient (CLL01).